HEMATOPOIETIC GROWTH-FACTORS FOR ANTITHYROID DRUG-INDUCED AGRANULOCYTOSIS

被引：0
|
作者：
GENET, P [1 ]
PULIK, M [1 ]
LIONNET, F [1 ]
BREMONT, C [1 ]
机构：
[1] HOP VICTOR DUPOUY,SERV ENDOCRINOL,F-95107 ARGENTEUIL,FRANCE
来源：
ANNALES D ENDOCRINOLOGIE | 1994年 / 55卷 / 01期
关键词：
ANTITHYROID DRUGS; AGRANULOCYTOSIS; G-CSF; GMCSF;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Agranulocytosis is the most serious problem, potentially fatal, that can occur during antithyroid drug therapy. The use of hematopoietic growth factors is an attractive approach to reduce the period of this drug-induced neutropenia. We report two cases of severe antithyroid drug-related agranulocytosis (granulocyte count < 0.1 X 10(9)/L) treated with Granulocyte Colony-Stimulating Factor (G-CSF) or Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF). The delay to observe a granulocyte count superior to 1 X 10(9)/L was respectively 1 and 5 days. Our results, with others, clearly show that hematopoietic growth factors are effective in severe antithyroid drug-induced agranulocytosis.
引用
收藏
页码：39 / 42
页数：4
相关论文
共 50 条
  • [21] Treatment of Drug-Induced Agranulocytosis with Haematopoietic Growth FactorsA Review of the Clinical Experience
    Thierry Vial
    Cédric Gallant
    Geneviève Choquet-Kastylevsky
    Jacques Descotes
    BioDrugs, 1999, 11 : 185 - 200
  • [22] antithyroid drug induced agranulocytosis: what still we need to learn ?
    PAN AFRICAN MEDICAL JOURNAL, 2016, 24
  • [23] Emphasis on the early diagnosis of antithyroid drug-induced agranulocytosis: retrospective analysis over 16 years at one Chinese center
    He, Y.
    Li, J.
    Zheng, J.
    Khan, Z.
    Qiang, W.
    Gao, F.
    Zhao, Y.
    Shi, B.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2017, 40 (07): : 733 - 740
  • [24] Retrospective analysis of 18 cases of antithyroid drug (ATD)-induced agranulocytosis
    Dai, WX
    Zhang, JD
    Zhan, SW
    Xu, BZ
    Jin, H
    Yao, Y
    Xin, WC
    Bai, Y
    ENDOCRINE JOURNAL, 2002, 49 (01) : 29 - 33
  • [25] RESPONSE OF HEMATOPOIETIC PRECURSOR CELLS TO HEMATOPOIETIC GROWTH-FACTORS IN THE MYELODYSPLASTIC SYNDROMES
    THOMAS, X
    CAMPOS, L
    BONNIER, S
    TRONCY, J
    GUYOTAT, D
    FIERE, D
    NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1990, 32 (05): : 345 - 347
  • [26] Ceftriaxone-Induced Reversible Agranulocytosis: A Case Report and Review of Drug-Induced Agranulocytosis
    Munir, Farrukh
    Javaid, Hafiza Wajeeha
    Rana, Muhammad Burhan Majeed
    Shaukat, Fatima
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (03)
  • [27] Emphasis on the early diagnosis of antithyroid drug-induced agranulocytosis: retrospective analysis over 16 years at one Chinese center
    Y. He
    J. Li
    J. Zheng
    Z. Khan
    W. Qiang
    F. Gao
    Y. Zhao
    B. Shi
    Journal of Endocrinological Investigation, 2017, 40 : 733 - 740
  • [28] Recognition and management of drug-induced blood cytopenias: the example of drug-induced acute neutropenia and agranulocytosis
    Andres, Emmanuel
    Federici, Laure
    Weitten, Thierry
    Vogel, Thomas
    Alt, Martine
    EXPERT OPINION ON DRUG SAFETY, 2008, 7 (04) : 481 - 489
  • [29] ALLOGENEIC MARROW TRANSPLANTATION AND THE USE OF HEMATOPOIETIC GROWTH-FACTORS
    APPELBAUM, FR
    STEM CELLS, 1995, 13 (04) : 344 - 350
  • [30] A case of antithyroid drug-induced agranulocytosis from a second antithyroid drugs (ATD) administration in a relapsed Graves' disease patient who was tolerant to the first ATD treatment
    Kim, Hyunsam
    Lee, Jeongmin
    Ha, Jeonghoon
    CLINICAL CASE REPORTS, 2018, 6 (09): : 1701 - 1703
12345